Dapagliflozin ((2S) -1,2-propanediol, hydrate)
Dapagliflozin propanediol monohydrate is a selective, orally active SGLT2 inhibitor developed for type 2 diabetes research. It blocks renal glucose reabsorption and is widely used in both in vitro binding assays and in vivo models of diabetes and heart failure to study metabolic and cardiovascular effects.
Product Specifications
CAS Number
960404-48-2
Product Name Alternative
Dapagliflozin ((2S) 1,2 propanediol, hydrate), Dapagliflozin ((2S) 1,2propanediol, hydrate), Dapagliflozin (1,2-propanediol, hydrate), Dapagliflozin propanediol, Dapagliflozin propanediol Monohydrate, Dapagliflozin propanediol monohydrate, BMS-512148 (2S) -1,2-propanediol, hydrate, BMS-512148 1,2-propanediol, Hydrate, Inhibitor, inhibit, Sodium-dependent glucose cotransporters, SGLT2, SGLT
Field of Research
Pharmacology & Drug Discovery
Purity
99.39% (May vary between batches)
Solubility
DMSO:50 mg/mL (99.41 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (3.98 mM)
Smiles
O.O[C@H]1[C@H] (O) [C@@H] (O) [C@@H] (O[C@@H]1CO) c3ccc (Cl) c (Cc2ccc (OCC) cc2) c3.C[C@H] (O) CO
Molecular Formula
C24H35ClO9
Molecular Weight
502.98
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog